Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study
- PMID: 25708218
- DOI: 10.1016/j.bbmt.2015.02.010
Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study
Abstract
Robust T cell function recovery has been shown to be crucial in determining allogeneic hematopoietic stem cell transplantation (HSCT) outcome, and there is growing evidence that the thymus plays a central role in regulating this process. We performed a long-term analysis of the role of thymic activity recovery in a population of pediatric patients undergoing allogeneic HSCT by signal joint T cell receptor excision circle (sjTREC) quantification. In this study, characterized by a long-term follow-up (median, 72 months), we found patients with higher levels of sjTRECs before transplantation had a statistically significant reduced risk of death compared with patients with lower values (relative risk, .31; 95% confidence interval, .30 to .32; P = .02), showing this different outcome was mainly related to a reduction of relapse incidence (14% versus 43%, P = .02). Unlike previous reports, we observed no correlation between sjTREC levels and lymphocyte recovery. Moreover, we confirmed that only graft-versus-host disease influenced thymic activity after transplantation. In conclusion, our results suggest an association between pretransplantation thymic activity and the long-term outcome of pediatric patients undergoing HSCT, mainly through a reduction of relapse opportunities.
Keywords: Allogeneic hematopoietic stem cell transplantation; Pediatric; sjTREC.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26. doi: 10.1016/j.bbmt.2015.03.018. Epub 2015 Mar 31. Biol Blood Marrow Transplant. 2015. PMID: 25840339
-
Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.Biol Blood Marrow Transplant. 2015 Jul;21(7):1266-72. doi: 10.1016/j.bbmt.2015.02.024. Epub 2015 Mar 10. Biol Blood Marrow Transplant. 2015. PMID: 25765555
-
Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.Biol Blood Marrow Transplant. 2015 Jun;21(6):1091-8. doi: 10.1016/j.bbmt.2015.02.007. Epub 2015 Feb 21. Biol Blood Marrow Transplant. 2015. PMID: 25708217
-
Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.Tissue Antigens. 2012 Feb;79(2):83-9. doi: 10.1111/j.1399-0039.2011.01820.x. Tissue Antigens. 2012. PMID: 22220718 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children.Cent Eur J Immunol. 2020;45(2):151-159. doi: 10.5114/ceji.2019.89843. Epub 2020 Feb 26. Cent Eur J Immunol. 2020. PMID: 33456325 Free PMC article.
-
Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT.Blood Res. 2019 Dec;54(4):274-281. doi: 10.5045/br.2019.54.4.274. Epub 2019 Dec 20. Blood Res. 2019. PMID: 31915654 Free PMC article.
-
Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach.J Blood Med. 2020 May 15;11:141-162. doi: 10.2147/JBM.S206027. eCollection 2020. J Blood Med. 2020. PMID: 32523389 Free PMC article. Review.
-
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome.Int J Mol Sci. 2016 Oct 11;17(10):1705. doi: 10.3390/ijms17101705. Int J Mol Sci. 2016. PMID: 27727179 Free PMC article. Review.
-
Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.Front Immunol. 2018 Jun 18;9:1237. doi: 10.3389/fimmu.2018.01237. eCollection 2018. Front Immunol. 2018. PMID: 29967605 Free PMC article. Review.